Efficient short-term control of hypercortisolaemia by low-dose etomidate in severe paediatric Cushing's disease

Hormone Research

Volumn 64, Issue 3, 2005, Pages 140-143

  Greening, J E ^a   Brain, C E ^b   Perry, L A ^a   Mushtaq, I ^b   Sales Marques, J ^c   Grossman, A B ^a   Savage, M O ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c CENTRO HOSPITALAR DE VILA NOVA DE GAIA ESPINHO   (Portugal)

Author keywords

Adrenalectomy; Etomidate; Paediatric Cushing's disease

Indexed keywords

ETOMIDATE; HYDROCORTISONE; KETOCONAZOLE; METYRAPONE;

ARTICLE; CASE REPORT; CHILDHOOD DISEASE; CLINICAL EXAMINATION; CUSHING SYNDROME; DISEASE CONTROL; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; GENERAL CONDITION DETERIORATION; HORMONAL THERAPY; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYPERCORTISOLISM; LABORATORY TEST; LOW DRUG DOSE; MALE; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; SHORT COURSE THERAPY; TITRIMETRY; TREATMENT OUTCOME;

ADRENALECTOMY; CHILD; CUSHING SYNDROME; ETOMIDATE; HUMANS; HYDROCORTISONE; KETOCONAZOLE; MALE; METYRAPONE;

EID: 27144479463     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088587     Document Type: Article

References (20)

1. Magiakou MA, Mastorakos G, Oldfield EH, Doppman JL, Cutler GB Jr, Nieman LK, Chrousos GP: Cushing's syndrome in children and adolescence: presentation, diagnosis, and therapy. N Engl J Med 1994;331:629-636.
2. Savage MO, Besser GM: Cushing's disease in childhood. Trends Endocrinol Metab 1996;7:213-216.
3. Verhelst A, Trainer PJ, Howlett TA, et al: Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome. Clin Endocrinol 1991;35:169-178.
4. Fahlbusch R, Honegger J, Buchfelder M: Neurosurgical management of Cushing's disease in children; in Savage MO, Bourguignon JP, Grossman AB (eds): Frontiers of Paediatric Neuroendocrinology. Oxford, Blackwell Scientific Publications, 1994, pp 68-72.
5. Storr HL, Plowman PN, Carroll PV, Francois I, Krassass G, Afshar F, Besser GM, Grossman AB, Savage MO: Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatment. J Clin Endocrinol Metab 2003;88:34-37.
6. Allolio B, Stuttmann R, Fischer H, Leonharp W, Winkelmann W: Long-term etomidate, and adrenocortical suppression. Lancet 1983;ii:626.
7. Schulte HM, Benker G, Reinwein D, Sippell WG, Allolio B: Infusion of low-dose etomidate: correction of hypercortisolemia in patients with Cushing's syndrome and dose-response relationship in normal subjects. J Clin Endocrinol Metab1990;70:1426-1430.
8. Gartner R, Albrecht M, Muller OA: Effect of etomidate on hypercortisolism due to ectopic ACTH production. Lancet 1986;i:275.
9. Drake WM, Perry LA, Hinds CJ, Lowe DG, Reznek RH, Besser GM: Emergency and prolonged use of intravenous etomidate to control hypercortisolemia in a patient with Cushing's syndrome and peritonitis. J Clin Endocrinol Metab 1998;83:3542-3544.
10. Rockall AG, Sohaib SA, Evans D, Kaltsas G, Isidori AM, Monson JP, Besser GM, Grossman AB, Reznek RH: Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography. Eur J Endocrinol 2003;149:543-548.
11. Newell-Price J, Trainer PJ, Besser GM, Grossman AB: The diagnosis and differential diagnosis of Cushing's and pseudo-Cushing's states. Endocr Rev 1998;19:647-672.
12. Sonino N, Boscaro M, Paoletta A, Mantero F, Ziliotto D: Ketoconazole treatment in Cushing's syndrome: experience in 34 patients. Clin Endocrinol 1991;35:347-352.
13. Krakoff J, Koch CA, Calis KA, Alexander RH, Nieman LK: Use of a parenteral propylene glycol-containing etomidate preparation for the long-term management of ectopic Cushing's syndrome. J Clin Endocrinol Metab 2001;86:4104-4108.
14. Ledingham IM, Watt I: Influence of sedation on mortality in critically ill multiple trauma patients. Lancet 1983;i:1270.
15. Watt I, Ledingham IM: Mortality amongst multiple trauma patients admitted to an intensive therapy unit. Anaesthesia 1984;39:973-981.
16. Klausen NO, Moelgaard J, Ferguson AH, Kaalund Jensen J, Larsen C, Paaby P: Negative synacthen test during etomidate infusion. Lancet 1983;i:848.
17. Lambert A, Mitchell R, Frost J, Ratcliffe JG, Roberts WR: Direct in vitro inhibition of adrenal steroidogenesis by etomidate. Lancet 1983;ii:1085-1086.
18. Lamberts SW, Bons EG, Bruining HA, de Jong FH: Differential effects of the imidazole derivatives etomidate, ketoconazole and miconazole and of metyrapone on the secretion of cortisol and its precursors by human adrenocortical cells. J Pharmacol Exp Ther 1987;240:259-264.
19. Allolio B, Dorr H, Stuttmann DK, Engelhardt D, Winkelmann W: Effect of a single bolus of etomidate upon eight major corticosteroid hormones and plasma ACTH. Clin Endocrinol 1985;21:281-286.
20. Dorr HG, Kühnle U, Holthausen H, Bidlingmaier F, Knorr D: Etomidate: A selective adrenocortical 11-beta-hydroxylase inhibitor. Klin Wochenschr 1984;62:1011-1013.